Lipella Pharmaceuticals I...
(LIPO)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 3.29M | 5.12M | 1.41M | 606.74K | 26.00K |
| Short-Term Investments | - | - | 300.55K | - | - |
| Long-Term Investments | - | - | - | - | - |
| Other Long-Term Assets | - | -150.82K | -204.80K | -255.59K | - |
| Receivables | 32.29K | 113.66K | - | 69.03K | 83.89K |
| Inventory | - | -113.66K | - | - | - |
| Other Current Assets | 103.26K | 563.89K | 93.72K | 23.66K | 92.91K |
| Total Current Assets | 3.43M | 5.80M | 1.81M | 699.43K | 118.92K |
| Property-Plant & Equipment | 147.89K | 150.82K | 204.80K | 255.59K | - |
| Goodwill & Intangibles | - | - | - | - | - |
| Total Long-Term Assets | 147.89K | 150.82K | 204.80K | 255.59K | - |
| Total Assets | 3.58M | 5.95M | 2.01M | 955.02K | 118.92K |
| Account Payables | 138.02K | 384.36K | 46.90K | 24.54K | 49.34K |
| Deferred Revenue | - | - | 178.97K | 24.99K | - |
| Short-Term Debt | 89.22K | 333.26K | 64.60K | 130.95K | 50.00K |
| Other Current Liabilities | 158.12K | 460.64K | -128.81K | 27.29K | 66.33K |
| Total Current Liabilities | 385.36K | 1.18M | 340.63K | 207.77K | 165.67K |
| Long-Term Debt | 47.37K | 96.26K | 218.36K | 257.96K | 50.00K |
| Other Long-Term Liabilities | - | - | 30.35K | 25.97K | 21.59K |
| Total Long-Term Liabilities | 47.37K | 96.26K | 248.71K | 283.94K | 71.59K |
| Total Liabilities | 432.73K | 1.27M | 589.34K | 491.70K | 237.26K |
| Total Debt | 136.59K | 429.52K | 282.96K | 388.91K | 100.00K |
| Common Stock | 605.00 | 574.00 | 967.00 | 574.00 | 520.00 |
| Retained Earnings | -10.32M | -5.70M | -3.11M | -1.24M | -1.18M |
| Comprehensive Income | - | - | -3.11M | -1.24M | -1.18M |
| Shareholders Equity | 3.14M | 4.68M | 1.42M | 463.32K | -118.34K |
| Total Investments | - | - | 300.55K | - | - |